Company
Headquarters: Singapore, Singapore
CEO: Dr. Yongxin Shao
S$31.7 Million
SGD as of Jan. 1, 2024
US$24.0 Million
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Aoxin Q & M Dental Group Limited, an investment holding company, provides private dental services, and dental equipment and supplies primarily in the People's Republic of China. The company offers private dental services, including stomatology and general dentistry, endodontics, orthodontics, periodontics, prosthodontics, dental implantology, oral and maxillofacial surgery, aesthetic dentistry, and paedodontics, as well as manages dental centers. As of December 31, 2020, it operated a total of 16 dental centers comprising 6 dental hospitals and 10 polyclinics in 8 cities in Liaoning Province. The company also distributes and sells dental equipment and supplies, such as dental chairs, ultrasound scanners, dental instruments, and materials and consumables to dental hospitals, clinics, distributors, and laboratories. In addition, it provides laboratory service, which includes the manufacturing of porcelain crown, bridges, and dentures; and leases dental equipment. The company was founded in 1997 and is based in Singapore.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Aoxin Q & M Dental Group Ltd has the following listings and related stock indices.
Stock: SGX: 1D4 wb_incandescent